- United States
- /
- Insurance
- /
- NYSE:LMND
Lemonade (LMND): Evaluating Valuation as Q3 Results Near and Revenue Momentum Builds
Reviewed by Simply Wall St
Lemonade (LMND) is catching investors’ attention ahead of its third-quarter earnings announcement on Nov. 5. With revenue growth accelerating and in-force premium topping $1 billion, expectations are high for the update.
See our latest analysis for Lemonade.
After a rocky start to the year, Lemonade’s 1-year total shareholder return has surged to 148%, reflecting renewed optimism about the company’s growth potential. The stock’s recent 62% share price return over the past three months signals that momentum is clearly building as investors anticipate the upcoming results.
If Lemonade’s rally has you watching for other high-momentum names, now is the perfect time to broaden your outlook and discover fast growing stocks with high insider ownership
With shares rallying ahead of earnings, the big question for investors is whether Lemonade is still trading at an attractive entry point or if the current price already reflects all of its future potential.
Most Popular Narrative: 26.9% Overvalued
Lemonade's latest consensus narrative values the shares at $46.50, a notable gap below the last close of $59.01. This disconnect is driving a heated debate about the true extent of Lemonade’s upside versus expectations already reflected in the market.
"The market may be pricing in continued high revenue growth driven by Lemonade's rapid expansion into new product lines and geographies. However, this optimism could be unwarranted if ongoing macroeconomic instability and persistent inflation reduce consumer discretionary spending and increase claim costs, which would negatively impact both revenue and net margins."
What is the engine behind this cautious fair value? These analysts are using bold revenue and earnings growth assumptions, betting Lemonade’s expansion momentum will be tested against tougher, shifting industry dynamics. Unpack the projections that are making bulls and bears clash over Lemonade’s future.
Result: Fair Value of $46.50 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, persistent competition in key markets and the risk of higher-than-expected claim costs could quickly challenge Lemonade’s optimistic growth and margin outlook.
Find out about the key risks to this Lemonade narrative.
Build Your Own Lemonade Narrative
If you think there’s more to Lemonade’s story or want to crunch the numbers yourself, you can dive in and build your own perspective in just a few minutes with Do it your way.
A great starting point for your Lemonade research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
Looking for more investment ideas?
If you want to stay ahead of the market and broaden your portfolio with smart stock picks, don’t miss out on these handpicked opportunities.
- Catch early movers by checking out these 3578 penny stocks with strong financials, which target high-growth sectors and overlooked gems with strong fundamentals.
- Unlock growth possibilities in healthcare technology and elevate your strategies with these 34 healthcare AI stocks, a resource making waves in medical innovation.
- Secure steady income and stability by tapping into these 24 dividend stocks with yields > 3%, featuring yields above 3% for those seeking robust long-term returns.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:LMND
Lemonade
Provides various insurance products in the United States, Europe, and the United Kingdom.
High growth potential with adequate balance sheet.
Similar Companies
Market Insights
Community Narratives

